Subscribe to RSS
DOI: 10.1055/a-1301-2378
The Role of Brown Adipose Tissue in the Development and Treatment of Nonalcoholic Steatohepatitis: An Exploratory Gene Expression Study in Mice
Funding Information This research was funded by a seeding grant of the School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, The Netherlands.Abstract
Brown adipose tissue (BAT) might be a beneficial mediator in the development and treatment of nonalcoholic steatohepatitis (NASH). We aim to evaluate the gene expression of BAT activity-related genes during the development and the dietary and surgical treatment of NASH. BAT was collected from male C57BL/6J mice that received a high fat-high sucrose diet (HF-HSD) or a normal chow diet (NCD) for 4 and 20 weeks (n=8–9 per dietary group and timepoint) and from mice that underwent dietary intervention (return to NCD) (n=8), roux-en-y gastric bypass (RYGB) (n=6), or sham procedure (n=6) after 12 weeks HF-HSD. Expression of BAT genes involved in lipid metabolism (Cd36 and Cpt1b; p<0.05) and energy expenditure (Ucp1 and Ucp3; p<0.05) were significantly increased after 4 weeks HF-HSD compared with NCD, whereas in the occurrence of NASH after 20 weeks HF-HSD no difference was observed. We observed no differences in gene expression regarding lipid metabolism or energy expenditure at 8 weeks after dietary intervention (no NASH) compared with HF-HSD mice (NASH), nor in mice that underwent RYGB compared with SHAM. However, dietary intervention and RYGB both decreased the BAT gene expression of inflammatory cytokines (Il1b, Tnf-α and MCP-1; p<0.05). Gene expression of the batokine neuregulin 4 was significantly decreased after 20 weeks HF-HSD (p<0.05) compared with NCD, but was restored by dietary intervention and RYGB (p<0.05). In conclusion, BAT is hallmarked by dynamic alterations in the gene expression profile during the development of NASH and can be modulated by dietary intervention and bariatric surgery.
Publication History
Received: 14 April 2020
Accepted after revision: 21 October 2020
Article published online:
01 December 2020
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Younossi ZM, Koenig AB, Abdelatif D. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016; 64: 73-84
- 2 Lonardo A, Nascimbeni F, Mantovani A. et al. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?. Journal of Hepatology 2018; 68: 335-352
- 3 Calzadilla Bertot L, Adams LA. The natural course of non-alcoholic fatty liver disease. Int J Mol Sci 2016; 17: 774
- 4 Wong RJ, Aguilar M, Cheung R. et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology 2015; 148: 547-555
- 5 Sumida Y, Yoneda M. Current and future pharmacological therapies for NAFLD/NASH. J Gastroenterol 2018; 53: 362-376
- 6 Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol 2015; 62: S47-S64
- 7 Scheja L, Heeren J. Metabolic interplay between white, beige, brown adipocytes and the liver. J Hepatol 2016; 64: 1176-1186
- 8 Busiello RA, Savarese S, Lombardi A. Mitochondrial uncoupling proteins and energy metabolism. Front Physiol 2015; 6: 36
- 9 Tutunchi H, Ostadrahimi A, Hosseinzadeh-Attar M-J. et al. A systematic review of the association of neuregulin 4, a brown fat–enriched secreted factor, with obesity and related metabolic disturbances. Obes Rev 2020; 21: e12952
- 10 Liu J, Xu Y, Hu Y. et al. The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy. Metabolism 2015; 64: 380-390
- 11 Poekes L, Gillard J, Farrell GC. et al. Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitis. Lab Invest 2019; 99: 4-16
- 12 van Marken Lichtenbelt WD, Vanhommerig JW, Smulders NM. et al. Cold-activated brown adipose tissue in healthy men. N Eng J Med 2009; 360: 1500-1508
- 13 Cypess AM, Lehman S, Williams G. et al. Identification and Importance of Brown Adipose Tissue in Adult Humans. N Eng J Med 2009; 360: 1509-1517
- 14 Yilmaz Y, Ones T, Purnak T. et al. Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans. Aliment Pharmacol Ther 2011; 34: 318-323
- 15 Baskin AS, Linderman JD, Brychta RJ. et al. Regulation of human adipose tissue activation, gallbladder size, and bile acid metabolism by a beta3-adrenergic receptor agonist. Diabetes 2018; 67: 2113-2125
- 16 Verbeek J, Jacobs A, Spincemaille P. et al. Development of a representative mouse model with nonalcoholic steatohepatitis. Curr Protoc Mouse. Biol 2016; 6: 201-210
- 17 Verbeek J, Lannoo M, Pirinen E. et al. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis. Gut 2015; 64: 673-683
- 18 Verbeek J, Spincemaille P, Vanhorebeek I. et al. Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice. Lipids Health Dis 2017; 16: 46
- 19 Bartelt A, Bruns OT, Reimer R. et al. Brown adipose tissue activity controls triglyceride clearance. Nat Med 2011; 17: 200
- 20 Townsend KL, Tseng Y-H. Brown Fat Fuel Utilization and Thermogenesis. Trends Endocrinol Metab 2014; 25: 168-177
- 21 Arrojo EDR, Fonseca TL, Werneck-de-Castro JP. et al. Role of the type 2 iodothyronine deiodinase (D2) in the control of thyroid hormone signaling. Biochim Biophys Acta 2013; 1830: 3956-3964
- 22 Gill JA, La Merrill MA. An emerging role for epigenetic regulation of Pgc-1α-expression in environmentally stimulated brown adipose thermogenesis. Environ Epigenet 2017; 3: dvx009
- 23 Hu J, Zhou H, Smyth A. et al. Polymorphism of the bovine ADRB3 gene. Mol Biol Rep 2010; 37: 3389-3392
- 24 Chan MY, Zhao Y, Heng CK. Sequential responses to high-fat and high-calorie feeding in an obese mouse model. Obesity (Silver Spring) 2008; 16: 972-978
- 25 Ohtomo T, Ino K, Miyashita R. et al. Chronic high-fat feeding impairs adaptive induction of mitochondrial fatty acid combustion-associated proteins in brown adipose tissue of mice. Biochem Biophys Rep 2017; 10: 32-38
- 26 Poekes L, Legry V, Schakman O. et al. Defective adaptive thermogenesis contributes to metabolic syndrome and liver steatosis in obese mice. Clin Sci (Lond) 2017; 131: 285-296
- 27 Fujita M, Momose A, Ohtomo T. et al. Upregulation of fatty acyl-CoA thioesterases in the heart and skeletal muscle of rats fed a high-fat diet. Biol Pharm Bull 2011; 34: 87-91
- 28 Mosca A, Nobili V, De Vito R. et al. Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents. J Hepatol 2017; 66: 1031-1036
- 29 Roberts-Toler C, O'Neill BT, Cypess AM. Diet-induced obesity causes insulin resistance in mouse brown adipose tissue. Obesity (Silver Spring, Md) 2015; 23: 1765-1770
- 30 Dinh CHL, Szabo A, Yu Y. et al. Bardoxolone methyl prevents fat deposition and inflammation in brown adipose tissue and enhances sympathetic activity in mice fed a high-fat diet. Nutrients 2015; 7: 4705-4723
- 31 Koves TR, Ussher JR, Noland RC. et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab 2008; 7: 45-56
- 32 Nøhr MK, Bobba N, Richelsen B. et al. Inflammation Downregulates UCP1 Expression in Brown Adipocytes Potentially via SIRT1 and DBC1 Interaction. Int J Mol Sci 2017; 18: 1006
- 33 Faria SL, Faria OP, Buffington C. et al. Energy expenditure before and after Roux-en-Y gastric bypass. Obes Surg 2012; 22: 1450-1455
- 34 GHEJ Vijgen, Bouvy ND, GJJ Teule. et al. Increase in Brown Adipose Tissue Activity after Weight Loss in Morbidly Obese Subjects. J Clin Endocrinol Metab 2012; 97: E1229-E1233
- 35 Hankir M, Bueter M, Gsell W. et al. Increased energy expenditure in gastric bypass rats is not caused by activated brown adipose tissue. Obes Facts 2012; 5: 349-358
- 36 Chen Y, Yang J, Nie X. et al. Effects of Bariatric Surgery on Change of Brown Adipocyte Tissue and Energy Metabolism in Obese Mice. Obes Surg 2018; 28: 820-830
- 37 Abegg K, Corteville C, Bueter M. et al. Alterations in energy expenditure in Roux-en-Y gastric bypass rats persist at thermoneutrality. Int J Obes 2016; 40: 1215
- 38 Chartoumpekis DV, Habeos IG, Ziros PG. et al. Brown adipose tissue responds to cold and adrenergic stimulation by induction of FGF21. Mol Med 2011; 17: 736-740
- 39 Wang GX, Zhao XY, Meng ZX. et al. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis. Nat Med 2014; 20: 1436-1443
- 40 Guo L, Zhang P, Chen Z. et al. Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression. J Clin Invest 2017; 127: 4449-4461
- 41 Chen Z, Wang G-X, Ma SL. et al. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders. Mol Metab 2017; 6: 863-872
- 42 Rao SR. Inflammatory markers and bariatric surgery: A meta-analysis. Inflamm Res 2012; 61: 789-807
- 43 Christiansen T, Paulsen SK, Bruun JM. et al. Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. Am J Physiol Endocrinol Metab 2010; 298: E824-E831